Clinical trial
A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , Versus Vehicle Foam in Subjects With Plaque-type Psoriasis
NCT00689481 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , Versus Vehicle Foam in Subjects With Plaque-type Psoriasis
- Lead sponsor
- Stiefel, a GSK Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- October 31, 2008
- Enrollment
- 323 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.